PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34256859-0	2021	Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway.	mir-100-5p	9-19	bone morphogenetic protein receptor type 2	Homo sapiens	98-103	
34256859-10	2021	The target relationship between miR-100-5p and BMPR2 was predicted and confirmed by a dual luciferase reporter assay and WB.	mir-100-5p	32-42	bone morphogenetic protein receptor type 2	Homo sapiens	47-52	
34256859-13	2021	MiR-100-5p expression was upregulated in the NONFH exosomes and inhibited the osteogenesis of hBMSCs and angiogenesis of HUVECs by targeting BMPR2 and suppressing the BMPR2/SMAD1/5/9 signalling pathway.	mir-100-5p	0-10	bone morphogenetic protein receptor type 2	Homo sapiens	141-146	
34256859-13	2021	MiR-100-5p expression was upregulated in the NONFH exosomes and inhibited the osteogenesis of hBMSCs and angiogenesis of HUVECs by targeting BMPR2 and suppressing the BMPR2/SMAD1/5/9 signalling pathway.	mir-100-5p	0-10	bone morphogenetic protein receptor type 2	Homo sapiens	167-172	
34256859-14	2021	Silencing miR-100-5p expression rescued the reduction in osteogenesis and angiogenesis caused by the NONFH exosomes by activating the BMPR2/SMAD1/5/9 signalling pathway.	mir-100-5p	10-20	bone morphogenetic protein receptor type 2	Homo sapiens	134-139	
34256859-15	2021	CONCLUSION: The NONFH exosomal miR-100-5p can lead to NONFH-like damage by targeting BMPR2 and suppressing the BMPR2/SMAD1/5/9 signalling pathway, which may be involved in the pathophysiological mechanisms of nontraumatic osteonecrosis of the femoral head (NONFH).	mir-100-5p	31-41	bone morphogenetic protein receptor type 2	Homo sapiens	85-90	
34256859-15	2021	CONCLUSION: The NONFH exosomal miR-100-5p can lead to NONFH-like damage by targeting BMPR2 and suppressing the BMPR2/SMAD1/5/9 signalling pathway, which may be involved in the pathophysiological mechanisms of nontraumatic osteonecrosis of the femoral head (NONFH).	mir-100-5p	31-41	bone morphogenetic protein receptor type 2	Homo sapiens	111-116	
35356885-10	2022	The upregulation of miR-100-5p in rBMSCs reduced the expressions of ALP, RUNX2, Col1, and BMPR2, and inhibited the osteogenic differentiation and migration abilities of rBMSCs.	mir-100-5p	20-30	bone morphogenetic protein receptor type 2	Homo sapiens	90-95